Literature DB >> 24160301

Balancing burdens and benefits: ethical issues of off-label prescription pharmaceutical use.

Ford Vox1, Alexander M Capron, Marilyn F Kraus, G Caleb Alexander, Kristi L Kirschner.   

Abstract

Mesh:

Year:  2013        PMID: 24160301     DOI: 10.1016/j.pmrj.2013.08.601

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.298


× No keyword cloud information.
  5 in total

1.  Immediate neurological recovery following perispinal etanercept years after brain injury.

Authors:  Edward Tobinick; Helen Rodriguez-Romanacce; Arthur Levine; Tracey A Ignatowski; Robert N Spengler
Journal:  Clin Drug Investig       Date:  2014-05       Impact factor: 2.859

2.  Patterns of Early Mental Health Diagnosis and Medication Treatment in a Medicaid-Insured Birth Cohort.

Authors:  Dinci Pennap; Julie M Zito; Paramala J Santosh; Sarah E Tom; Eberechukwu Onukwugha; Laurence S Magder
Journal:  JAMA Pediatr       Date:  2018-06-01       Impact factor: 16.193

Review 3.  Use of contrast media in diagnostic imaging: medico-legal considerations.

Authors:  C Pomara; N Pascale; F Maglietta; M Neri; I Riezzo; E Turillazzi
Journal:  Radiol Med       Date:  2015-06-17       Impact factor: 3.469

4.  Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.

Authors:  Tracey A Ignatowski; Robert N Spengler; Krishnan M Dhandapani; Hedy Folkersma; Roger F Butterworth; Edward Tobinick
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

5.  When are medical apps medical? Off-label use and the Food and Drug Administration.

Authors:  William H Krieger
Journal:  Digit Health       Date:  2016-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.